Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Dutasteride and finasteride affect different cell types differently.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Tamsulosin is a cost-effective treatment for BPH symptoms.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Rats had lasting erectile problems after stopping a certain medication.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New compounds with carborane showed anti-androgen effects similar to flutamide.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

New steroids were effective in blocking male hormone receptors in hamster prostates.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.